150 related articles for article (PubMed ID: 26741162)
41. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
42. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
43. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
[TBL] [Abstract][Full Text] [Related]
44. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
Yu B; Tang C; Yin C
Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
[TBL] [Abstract][Full Text] [Related]
45. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.
Cui R; Kim T; Fassan M; Meng W; Sun HL; Jeon YJ; Vicentini C; Tili E; Peng Y; Scarpa A; Liang G; Zhang YK; Chakravarti A; Croce CM
Oncotarget; 2015 Sep; 6(26):21802-15. PubMed ID: 26307684
[TBL] [Abstract][Full Text] [Related]
47. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
48. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
[TBL] [Abstract][Full Text] [Related]
49. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.
Lee HY; Mohammed KA; Kaye F; Sharma P; Moudgil BM; Clapp WL; Nasreen N
Int J Nanomedicine; 2013; 8():4481-94. PubMed ID: 24293999
[TBL] [Abstract][Full Text] [Related]
50. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
51. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
52. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
[TBL] [Abstract][Full Text] [Related]
53. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
54. A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML.
Yuan Y; Zhang L; Cao H; Yang Y; Zheng Y; Yang XJ
Biomed Res Int; 2016; 2016():1287128. PubMed ID: 27034925
[TBL] [Abstract][Full Text] [Related]
55. Amelioration of colorectal cancer using negative lipidoid nanoparticles to encapsulate siRNA against APRIL by enema delivery mode.
Ding W; Wang G; Shao K; Wang F; Huang H; Ju S; Cong H; Wang H
Pathol Oncol Res; 2014 Oct; 20(4):953-64. PubMed ID: 24771268
[TBL] [Abstract][Full Text] [Related]
56. Prenyl Ammonium Salts--New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
Grecka E; Statkiewicz M; Gorska A; Biernacka M; Grygorowicz MA; Masnyk M; Chmielewski M; Gawarecka K; Chojnacki T; Swiezewska E; Malecki M
PLoS One; 2016; 11(4):e0153633. PubMed ID: 27088717
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA delivery by cationic lipoplexes for lung cancer therapy.
Wu Y; Crawford M; Yu B; Mao Y; Nana-Sinkam SP; Lee LJ
Mol Pharm; 2011 Aug; 8(4):1381-9. PubMed ID: 21648427
[TBL] [Abstract][Full Text] [Related]
58. Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery.
Wan Y; Wang L; Zhu C; Zheng Q; Wang G; Tong J; Fang Y; Xia Y; Cheng G; He X; Zheng SY
Cancer Res; 2018 Feb; 78(3):798-808. PubMed ID: 29217761
[TBL] [Abstract][Full Text] [Related]
59. A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA.
Luo C; Miao L; Zhao Y; Musetti S; Wang Y; Shi K; Huang L
Biomaterials; 2016 Sep; 102():239-48. PubMed ID: 27344367
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
Cheng CJ; Bahal R; Babar IA; Pincus Z; Barrera F; Liu C; Svoronos A; Braddock DT; Glazer PM; Engelman DM; Saltzman WM; Slack FJ
Nature; 2015 Feb; 518(7537):107-10. PubMed ID: 25409146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
